Cullinan Therapeutics Inc CGEM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:19 PM EDT
22.93quote price arrow down-0.88 (-3.67%)
Volume
289,296
52 week range
7.64 - 30.19
Loading...
  • Open23.76
  • Day High24.26
  • Day Low22.75
  • Prev Close23.81
  • 52 Week High30.19
  • 52 Week High Date05/07/24
  • 52 Week Low7.64
  • 52 Week Low Date12/12/23

Key Stats

  • Market Cap1.322B
  • Shares Out57.63M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.06
  • YTD % Change126.1

KEY STATS

  • Open23.76
  • Day High24.26
  • Day Low22.75
  • Prev Close23.81
  • 52 Week High30.19
  • 52 Week High Date05/07/24
  • 52 Week Low7.64
  • 52 Week Low Date12/12/23
  • Market Cap1.322B
  • Shares Out57.63M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.06
  • YTD % Change126.1

RATIOS/PROFITABILITY

  • EPS (TTM)-3.70
  • P/E (TTM)-6.19
  • Fwd P/E (NTM)-6.89
  • EBITDA (TTM)-190.339M
  • ROE (TTM)-30.98%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-356.25%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cullinan Therapeutics Inc

 

Profile

MORE
Cullinan Therapeutics, Inc., formerly Cullinan Oncology, Inc., is a biopharmaceutical company focused on developing modality-agnostic targeted therapies. It has a portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its pipeline includes CLN-619, CLN-978, Zipalertinib (CLN-081/TAS6417), CLN-049, CLN-418, and CLN-617. Its lead unpartnered program, CLN-619, is a...
Anthony Rosenberg
Independent Chairman of the Board
Nadim Ahmed
President, Chief Executive Officer, Director
Mary Fenton
Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer
Jeffrey Trigilio
Chief Financial Officer, Treasurer
Address
One Main Street, Suite 1350
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
PHVS
Pharvaris NV
20.74-0.97-4.47%
ELVN
Enliven Therapeutics Inc
23.01-0.80-3.36%
SRRK
Scholar Rock Holding Corp
13.41-0.91-6.35%
BLTE
Belite Bio Inc
43.30+0.92+2.16%
CATX
Perspective Therapeutics Inc
1.60+0.07+4.58%